Assignee
ADT PHARMACEUTICALS INC
US·2 granted patents·2 pending applications·27 citations·filing 2014–2016
Top patents by PatentIndex Score
4 records- 0193US9931315B2Method of selectively inhibiting Ras-mediated tumor growth in humansADT PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·14 cites·3 claims
- 0291US9862698B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS INC·Filed 2014·Granted Jan 9, 2018·13 cites·19 claims
- 0361US2016168108A1Method of treating or preventing ras-mediated diseasesADT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0445US2017342021A1Ras-inhibiting indenyl acetamide compounds, compositions, and usesADT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →